SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus, Why the Slide?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: OmertaSoldier who wrote (3683)9/20/1997 7:09:00 PM
From: Rubble   of 3991
 
VVUS looks stronger now than it's ever been before. It's in much better shape than February, when it hit 40. For at that time, VVUS still did not have a profitable quarter (from product revs) under it's belt, and the short interest then was just 4 million. Now with two blow-out quarters, an impending additional earnings blow-out, and 2.5x the February short-interest, I think we'll see the big squeeze very soon. When I take into consideration that Vinick is now involved, which is likely to attract a lot more interest from Wall Street, I'm doubly reassured of VVUS' strength.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News